FDA authorizes Merck’s COVID-19 antiviral pill
The molnupiravir drug is cleared for use for adults 18 and older who have tested positive for COVID-19 and are at high risk of hospitalization.
(Click On Video to Unmute)
The molnupiravir drug is cleared for use for adults 18 and older who have tested positive for COVID-19 and are at high risk of hospitalization.